NDAIRRIGATIONSOLUTION
Approved
Jun 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BETAPRONE (propiolactone) by Forest Devices is antibodies. Approved for rabies in all age groups. First approved in 1959.
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BETAPRONE (propiolactone) is a solution for irrigation approved in 1959 as an NDA for rabies treatment across all age groups. It works through an antibody-based mechanism of action delivered via topical irrigation.
LOE Approaching
Product is in decline phase with no active job openings, indicating minimal commercial team investment and likely organizational focus shift.
Mechanism of Action
antibodies.
Indications (1)
Career Relevance
With zero linked job openings and a product in LOE-approaching lifecycle stage, BETAPRONE represents a maintenance-only assignment with minimal career growth potential. Career opportunities are limited to legacy brand management and compliance roles at sponsor Forest Devices.
Field Sales
Worked on BETAPRONE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.